Preventive effect of behavioral therapy plus flunarizine in children with migraine

CHEN Yan-Zhao; LI Ning; ZHOU Ke-Ying

doi:10.7499/j.issn.1008-8830.2014.11.006

PDF(1177 KB)

Chinese Journal of Contemporary Pediatrics ›› 2014, Vol. 16 ›› Issue (11) : 1105-1108. DOI: 10.7499/j.issn.1008-8830.2014.11.006

CLINICAL RESEARCH

Preventive effect of behavioral therapy plus flunarizine in children with migraine

CHEN Yan-Zhao¹, LI Ning², ZHOU Ke-Ying¹

Author information +

History +

Abstract

Objective To investigate the preventive effect of behavioral therapy plus flunarizine in children withmigraine. Methods Ninety pediatric patients with migraine between January 2011and January 2014 were randomlydivided into treatment group (45 cases) and control group (45 cases). The treatment group received behavioral therapy in addition to oral flunarizine, while the control group received oral flunarizine alone. All patients were followed upfor 3 months to evaluate the therapeutic effect by the Pediatric Migraine Disability Assessment Score (PedMIDAS)and improved Bussone headache index. Results There were no significant differences in Ped MIDAS (P>0.05) andimproved Bussone headache index (P>0.05) between the control and treatment groups before treatment. Significantdifferences were observed in PedMIDAS (16±8 vs 20±10; P<0.05) and improved Bussone headache index (25±18 vs37±21; P<0.05) between the two groups after 3 months of treatment. Conclusions Preventive treatment of behavioraltherapy plus oral flunarizine shows a better clinical efficacy than oral flunarizine alone in children with migraine andholds promise for clinical application.

Key words

Migraine / Preventive treatment / Behavioral therapy / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CHEN Yan-Zhao, LI Ning, ZHOU Ke-Ying. Preventive effect of behavioral therapy plus flunarizine in children with migraine[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(11): 1105-1108 https://doi.org/10.7499/j.issn.1008-8830.2014.11.006

References

[1] Lewis D, Ashwal S, Hershey A, et al. Practice parameter:pharmacological treatment of migraine headache in children and adolescents:report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society[J]. Neurology, 2004, 63(12):2215-2224.
[2] Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents a randomized clinical trial[J]. JAMA, 2013, 310(24):2622-2630.
[3] Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelines[J]. Neuropsychiatr Dis Treat, 2013, 9:709-720.
[4] 周克英, 文飞球, 王玉珍, 等. 发作间期脑血流动力学改变对偏头痛预防性治疗效果的影响[J]. 中国当代儿科杂志, 2004, 6(3):207-210.
[5] Connelly M. Cognitive behavioral therapy for treatment of pediatric chronic migraine[J]. JAMA, 2013, 310(24):2617-2618.
[6] Shapiro RE. Preventive treatment of migraine[J]. Headache, 2012, 52(Suppl 2N):65-69.
[7] Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed[J]. Cephalalgia, 2004, 24(Suppl 1):9-160.
[8] Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS:Development of a questionnaire to assess disability of migraines in children[J]. Neurology, 2001, 57(11):2034-2039.
[9] Bussone G, Baldini S, Andrea DG, et al. Nimodipine versus flunarizine in common migraine:a controlled pilot trial[J]. Headache, 1987, 27(2):76-79.
[10] Silberstein SD. Preventive migraine treatment[J]. Neurol Clin, 2009, 27(2):429-443.
[11] Rizzoli PB. Acute and preventive treatment of migraine[J]. Continuum (Minneap Minn), 2012, 18(4):764-782.
[12] Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity:a review of clinical findings[J]. J Headache Pain, 2011, 12(2):115-125.
[13] 张海菊, 王玉玮, 孙若鹏, 等. 偏头痛患儿的心理行为特征研究[J]. 中国儿童保健杂志, 2007, 15(4):357-359.
[14] Baskin SM, Smitherman TA. Migraine and psychiatric disorders:comorbidities,mechanisms, and clinical applications[J]. Neurol Sci, 2009, 30(1 Suppl):61-65.
[15] Seng EK, Holroyd KA. Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial[J]. Cephalalgia, 2012, 32(5):390-400.
[16] Buse DC, Andrasik F. Behavioral medicine for migraine[J]. Neurol Clin, 2009, 27(2):445-465.
[17] Rains JC, Penzien DB. Behavioral treatment strategies for migraine and tension-type headache:a review of the evidence and future directions[J]. Expert Rev Neurother, 2002, 2(5):749-760.
[18] Pistoia F, Sacco S, Carolei A. Behavioral therapy for chronic migraine[J]. Curr Pain Headache Rep, 2013, 17(1):304.
[19] Voerman JS, Klerk CD, Merelle SY, et al. Long-term followup of home-based behavioral management training provided by migraine patients[J]. Cephalalgia, 2014, 34(5):357-364.
[20] Hedborg K, Muhr C. The influence of multimodal behavioral treatment on the consumption of acute migraine drugs:a randomized, controlled study[J]. Cephalalgia, 2012, 32(4):297-307.
[21] Hedborg K, Muhr C. Multimodal behavioral treatment of migraine:an internet-administered, randomized, controlled trial[J]. Ups J Med Sci, 2011, 116(3):169-186.
[22] Cottrell C, Drew J, Gibson J, et al. Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine[J]. Headache, 2007, 47(9):1293-1302.